Novartis contest seeks user-generated content

Share this article:
Marketers from Novartis Vaccines and Diagnostics have jumped into the user-generated content arena with a contest that invites Web-savvy filmmakers to submit their work and compete for a cash prize.

With its “FluFlix Video Contest,” posted on YouTube during the months of September and October, Novartis asked consumers to create their own two-minute videos showing how they “feel about influenza…and how it can affect your everyday life.”

“For the first time ever, the flu can make you famous,” the contest rules read.

Submissions were sought in the following three categories: “kids and the flu,” “sports and the flu” and “workplace and the flu.” The winner of each one of the three contest categories was promised a $500 prize. Winners were scheduled to be revealed on November 19, 2007.

A Novartis spokesman was not immediately available for comment on the “FluFlix Video Contest” at press time.

Novartis Vaccines and Diagnostics plans to ship more than 60 million doses of its flu vaccine Fluvirin to the US for the 2007-2008 flu season.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...